These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1135868)

  • 1. Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors.
    Fuller RW; Snoody HD
    Toxicol Appl Pharmacol; 1975 Apr; 32(1):129-34. PubMed ID: 1135868
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the tranylcypromine-meperidine interaction: effects of p-chlorophenylalanine and l-5-hydroxytryptophan.
    Gessner PK; Soble AG
    J Pharmacol Exp Ther; 1973 Aug; 186(2):276-87. PubMed ID: 4268957
    [No Abstract]   [Full Text] [Related]  

  • 3. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.
    Rogers KJ; Thornton JA
    Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.
    Boden R; Botting R; Coulson P; Spanswick G
    Br J Pharmacol; 1984 May; 82(1):151-4. PubMed ID: 6428496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blockade of serotonin uptake and the meperidine-monoamine oxidase inhibitor interaction.
    Sinclair JG; Lo GF
    Proc West Pharmacol Soc; 1977; 20():373-4. PubMed ID: 19768
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification by monoamine oxidase inhibitors of the analgesic, hypothermic and toxic actions of morphine and pethidine in mice.
    Botting R; Bower S; Eason CT; Hutson PH; Wells L
    J Pharm Pharmacol; 1978 Jan; 30(1):36-40. PubMed ID: 22722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of butorphanol, with monoamine oxidase inhibitor, tranylcypromine.
    Gomaa AA; Mohammed LH; Ahmed HN; Farghaly AM
    Forensic Sci Int; 1991 Mar; 49(2):185-92. PubMed ID: 1855717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.
    Villégier AS; Salomon L; Blanc G; Godeheu G; Glowinski J; Tassin JP
    Eur J Neurosci; 2006 Sep; 24(5):1359-65. PubMed ID: 16965547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity secondary to meperidine in patients on monoamine oxidase inhibitors: a case report and critical review.
    Meyer D; Halfin V
    J Clin Psychopharmacol; 1981 Sep; 1(5):319-21. PubMed ID: 7334144
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of tranylcypromine upon 5-hydroxytryptaminergic neurons of rat brain stem.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1966; 14(4):365-70. PubMed ID: 5952329
    [No Abstract]   [Full Text] [Related]  

  • 13. The blockade of serotonin uptake into synaptosomes:relationship to an interaction with monoamine oxidase inhibitors.
    Sinclair JG; Lo GF
    Can J Physiol Pharmacol; 1977 Apr; 55(2):180-7. PubMed ID: 17455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of monoamine oxidase inhibitors on the concentrations of dopamine and serotonin in the striatum of the cat with and without unilateral brainstem lesions.
    Singh P; Poirier LJ; Boucher R
    Can J Physiol Pharmacol; 1967 Sep; 45(5):897-904. PubMed ID: 6049616
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain structures involved in the behavioral stimulant effect of central serotonin release.
    Vanderwolf CH; McLauchlin M; Dringenberg HC; Baker GB
    Brain Res; 1997 Oct; 772(1-2):121-34. PubMed ID: 9406964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release.
    Sharp T; Gartside SE; Umbers V
    Eur J Pharmacol; 1997 Feb; 320(1):15-9. PubMed ID: 9049597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranylcypromine in mind (Part I): Review of pharmacology.
    Ulrich S; Ricken R; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):697-713. PubMed ID: 28655495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.